Skip to main content
. 2014 Mar;52(3):931–939. doi: 10.1128/JCM.02868-13

TABLE 1.

Identification results obtained using rpoB gene sequencing and three commercial systems, antimicrobial susceptibility, and genotyping results for the 11 bloodstream isolates of Acinetobacter GS 13BJ/14TU

Isolate no. Date of isolation (yr-mo-day) Species identified by:
Antimicrobial susceptibilityb MLSTc
PFGEg pattern
rpoB gene sequence analysisa Vitek 2a MicroScana API 20 NE
Resulta Code no. Allele profiled STf
1 2003-10-07 Acinetobacter GS 13BJ/14TU (97) A. baumannii complex (95) A. baumannii/haemolyticus (99.99) A. haemolyticus (95.2) 0010053 All S, except colistin (R) 18-22-42e −11-21-14-21 198e P1
2 2004-03-15 Acinetobacter GS 13BJ/14TU (100) A. baumannii complex (96) A. lwoffii (99.99) A. haemolyticus (99.9) 0010051 All S, except colistin (R) 21-25-24-15-24-17-24 69 P2
3 2005-10-18 Acinetobacter GS 13BJ/14TU (97) A. baumannii complex (99) A. baumannii/haemolyticus (98.18) A. haemolyticus (95.2) 0010053 All S, except tetracycline (R) and colistin (R) 18-22-42e-11-21-14-21 198e P3
4 2008-08-03 Acinetobacter GS 13BJ/14TU (100) A. baumannii complex (98) A. baumannii/haemolyticus (98.18) A. haemolyticus (95.2) 0010053 All S, except colistin (R) 21-25-24-28e-46e-17-24 200e P4
5 2009-07-24 Acinetobacter GS 13BJ/14TU (99) A. baumannii complex (99) A. baumannii/haemolyticus (98.18) A. haemolyticus (95.2) 0010053 All S, except colistin (R) 21-25-42e-15-24-17-24 201e P5
6 2009-10-01 Acinetobacter GS 13BJ/14TU (97) A. baumannii complex (98) A. baumannii/haemolyticus (98.18) A. haemolyticus (99.9) 0010051 All S, except colistin (R) 18-22-42e-11-21-14-21 198e P6
7 2009-11-03 Acinetobacter GS 13BJ/14TU (97) A. baumannii complex (99) A. baumannii/haemolyticus (66.99) A. haemolyticus (95.2) 0010053 All S, except colistin (R) 18-22-42e-11-21-14-21 198e P7
8 2010-05-11 Acinetobacter GS 13BJ/14TU (99) A. baumannii complex (99) A. baumannii/haemolyticus (95.16) A. haemolyticus (95.2) 0010053 All S, except colistin (R) 18-22-42e-11-21-14-24 199e P8
9 2010-07-03 Acinetobacter GS 13BJ/14TU (97) A. lwoffii (97) A. baumannii/haemolyticus (98.18) A. haemolyticus (95.2) 0010053 All S, except colistin (R) 18-22-42e-11-21-14-21 198e P9
10 2011-07-11 Acinetobacter GS 13BJ/14TU (97) A. baumannii complex (99) A. baumannii/haemolyticus (98.18) A. haemolyticus (95.2) 0010053 All S, except ciprofloxacin (I) and colistin (R) 18-22-42e-11-21-14-21 198e P10
11 2011-08-09 Acinetobacter GS 13BJ/14TU (99) A. baumannii complex (99) P. stuartii (75.88) A. haemolyticus (95.2) 0010053 All S, except colistin (R) 21-25-24-28e-46e-17-24 200e P11
ATCC 17905 Acinetobacter GS 13BJ/14TU (100) A. baumannii complex (98) A. baumannii/haemolyticus (98.18) A. haemolyticus (95.2) 0010053 All S, except colistin (R) 21-25-24-15-24-17-24 69 P12
a

Numbers in parentheses are the probabilities of correct identification (as percentages).

b

Antimicrobial susceptibility testing was performed using the disk diffusion method for ampicillin-sulbactam, piperacillin-tazobactam, ticarcillin-clavulanic acid, ceftazidime, cefepime, ceftriaxone, imipenem, meropenem, gentamicin, tobramycin, amikacin, tetracycline, and ciprofloxacin; colistin susceptibility was determined using the agar dilution method. S, susceptible; I, intermediate; R, resistant.

c

MLST, multilocus sequence typing.

d

Allele profiles for cpn60-fusA-gltA-pyrG-recA-rplB-rpoB.

e

Three new alleles and four new STs identified in this study were added to the Institut Pasteur MLST database (http://www.pasteur.fr/mlst).

f

ST, sequence type.

g

PFGE, pulsed-field gel electrophoresis.